| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.712 | 0.005 | 0.712 | Cardiotonic | 0.612 0.007 DBMET01809 0.62 0.007 DBMET01810 0.594 0.008 DBMET01811 | ||
| 0.617 | 0.004 | 0.617 | Anesthetic local | 0.513 0.004 DBMET01809 0.564 0.004 DBMET01810 0.471 0.005 DBMET01811 | ||
| 0.568 | 0.005 | 0.568 | Sigma receptor agonist | 0.539 0.007 DBMET01809 0.535 0.007 DBMET01810 0.355 0.029 DBMET01811 | ||
| 0.558 | 0.017 | 0.603 | Spasmolytic | 0.603 0.013 DBMET01809 0.599 0.013 DBMET01810 0.397 0.04 DBMET01811 | DBMET01809 | |
| 0.512 | 0.031 | 0.69 | Aldehyde oxidase inhibitor | 0.69 0.009 DBMET01809 0.675 0.01 DBMET01810 | DBMET01809 | |
| 0.485 | 0.016 | 0.485 | Potassium channel (Voltage-sensitive) blocker | 0.237 0.074 DBMET01809 0.25 0.067 DBMET01810 0.3 0.049 DBMET01811 | ||
| 0.42 | 0.019 | 0.42 | Potassium channel blocker | 0.187 0.101 DBMET01809 0.204 0.09 DBMET01810 0.241 0.071 DBMET01811 | ||
| 0.416 | 0.03 | 0.424 | Vasodilator, coronary | 0.417 0.03 DBMET01809 0.424 0.028 DBMET01810 0.393 0.038 DBMET01811 | DBMET01810 | |
| 0.365 | 0.005 | 0.365 | Calcium channel blocker | 0.244 0.018 DBMET01809 0.258 0.015 DBMET01810 0.322 0.008 DBMET01811 | ||
| 0.368 | 0.012 | 0.46 | Tyrosine 3 hydroxylase inhibitor | 0.428 0.006 DBMET01809 0.46 0.005 DBMET01810 0.295 0.035 DBMET01811 | DBMET01810 | |
| 0.375 | 0.02 | 0.403 | Anesthetic general | 0.387 0.018 DBMET01809 0.403 0.016 DBMET01810 0.235 0.057 DBMET01811 | DBMET01810 | |
| 0.398 | 0.046 | 0.707 | 5 Hydroxytryptamine release stimulant | 0.439 0.038 DBMET01809 0.415 0.043 DBMET01810 0.707 0.007 DBMET01811 | DBMET01811 | |
| 0.332 | 0.007 | 0.332 | Acetylcholine muscarinic antagonist | 0.308 0.009 DBMET01809 0.332 0.007 DBMET01810 0.278 0.011 DBMET01811 | ||
| 0.331 | 0.012 | 0.331 | Cholinergic antagonist | 0.297 0.015 DBMET01809 0.312 0.013 DBMET01810 0.268 0.018 DBMET01811 | ||
| 0.322 | 0.012 | 0.322 | Acetylcholine antagonist | 0.287 0.015 DBMET01809 0.303 0.014 DBMET01810 0.264 0.018 DBMET01811 | ||
| 0.304 | 0.005 | 0.304 | Sigma receptor antagonist | 0.179 0.009 DBMET01809 0.183 0.009 DBMET01810 0.116 0.014 DBMET01811 | ||
| 0.301 | 0.006 | 0.301 | Fibroblast growth factor 1 antagonist | 0.208 0.015 DBMET01809 0.209 0.014 DBMET01810 0.229 0.011 DBMET01811 | ||
| 0.308 | 0.022 | 0.35 | Peptidyltransferase inhibitor | 0.303 0.023 DBMET01809 0.312 0.021 DBMET01810 0.35 0.012 DBMET01811 | DBMET01811 | |
| 0.285 | 0.004 | 0.331 | Prolactin inhibitor | 0.331 0.003 DBMET01809 0.33 0.003 DBMET01810 0.207 0.008 DBMET01811 | DBMET01809 | |
| 0.297 | 0.02 | 0.297 | Neuropeptide Y2 antagonist | 0.291 0.023 DBMET01809 0.297 0.02 DBMET01810 0.277 0.033 DBMET01811 | ||
| 0.283 | 0.007 | 0.309 | 5 Hydroxytryptamine 1 agonist | 0.107 0.019 DBMET01809 0.11 0.019 DBMET01810 0.309 0.006 DBMET01811 | DBMET01811 | |
| 0.385 | 0.115 | 0.43 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.43 0.076 DBMET01811 | DBMET01811 | |
| 0.265 | 0.004 | 0.265 | Dopamine D2 agonist | 0.241 0.005 DBMET01809 0.252 0.005 DBMET01810 0.263 0.004 DBMET01811 | ||
| 0.363 | 0.104 | 0.389 | 5 Hydroxytryptamine release inhibitor | 0.389 0.085 DBMET01809 0.387 0.086 DBMET01810 0.259 0.216 DBMET01811 | DBMET01809 | |
| 0.27 | 0.012 | 0.27 | Nav1.3 sodium channel blocker | 0.186 0.03 DBMET01809 0.2 0.024 DBMET01810 0.263 0.012 DBMET01811 | ||
| 0.377 | 0.125 | 0.467 | Caspase 9 stimulant | 0.467 0.074 DBMET01809 0.447 0.085 DBMET01810 | DBMET01809 | |
| 0.243 | 0.005 | 0.243 | Acetylcholine M2 receptor antagonist | 0.19 0.007 DBMET01809 0.214 0.006 DBMET01810 0.19 0.007 DBMET01811 | ||
| 0.285 | 0.047 | 0.33 | Psychostimulant | 0.259 0.055 DBMET01809 0.27 0.051 DBMET01810 0.33 0.035 DBMET01811 | DBMET01811 | |
| 0.266 | 0.029 | 0.266 | Lipocortins synthesis antagonist | 0.261 0.03 DBMET01809 0.243 0.036 DBMET01810 0.135 0.13 DBMET01811 | ||
| 0.242 | 0.011 | 0.242 | Ca(v)2.2 blocker | 0.125 0.037 DBMET01809 0.145 0.03 DBMET01810 0.227 0.013 DBMET01811 | ||
| 0.25 | 0.022 | 0.25 | Nav1.2 sodium channel blocker | 0.189 0.039 DBMET01809 0.202 0.034 DBMET01810 0.155 0.054 DBMET01811 | ||
| 0.235 | 0.008 | 0.237 | Dopamine agonist | 0.227 0.008 DBMET01809 0.23 0.008 DBMET01810 0.237 0.007 DBMET01811 | DBMET01811 | |
| 0.227 | 0.003 | 0.227 | Sodium/calcium exchanger inhibitor | 0.15 0.004 DBMET01809 0.152 0.004 DBMET01810 0.151 0.004 DBMET01811 | ||
| 0.278 | 0.058 | 0.329 | 5 Hydroxytryptamine uptake stimulant | 0.273 0.061 DBMET01809 0.273 0.061 DBMET01810 0.329 0.032 DBMET01811 | DBMET01811 | |
| 0.223 | 0.004 | 0.223 | Fibroblast growth factor 4 antagonist | 0.136 0.005 DBMET01809 0.146 0.005 DBMET01810 0.202 0.004 DBMET01811 | ||
| 0.225 | 0.013 | 0.225 | Calcium channel (voltage-sensitive) blocker | 0.131 0.046 DBMET01809 0.143 0.038 DBMET01810 0.189 0.019 DBMET01811 | ||
| 0.264 | 0.059 | 0.264 | 5 Hydroxytryptamine 1E antagonist | 0.263 0.061 DBMET01809 0.256 0.068 DBMET01810 0.229 0.098 DBMET01811 | ||
| 0.263 | 0.067 | 0.332 | Superoxide dismutase inhibitor | 0.332 0.041 DBMET01809 0.329 0.042 DBMET01810 0.246 0.077 DBMET01811 | DBMET01809 | |
| 0.188 | 0.004 | 0.188 | Complement C5a chemotactic receptor antagonist | 0.114 0.005 DBMET01809 0.129 0.005 DBMET01810 0.171 0.004 DBMET01811 | ||
| 0.211 | 0.03 | 0.211 | Acetylcholinesterase inhibitor | 0.201 0.033 DBMET01809 0.186 0.038 DBMET01810 0.123 0.076 DBMET01811 | ||
| 0.185 | 0.007 | 0.185 | CXC chemokine receptor antagonist | 0.131 0.014 DBMET01809 0.144 0.011 DBMET01810 0.171 0.008 DBMET01811 | ||
| 0.215 | 0.04 | 0.215 | Cholinergic | 0.183 0.055 DBMET01809 0.171 0.061 DBMET01810 0.119 0.109 DBMET01811 | ||
| 0.19 | 0.019 | 0.202 | Calcium channel N-type blocker | 0.115 0.069 DBMET01809 0.126 0.056 DBMET01810 0.202 0.016 DBMET01811 | DBMET01811 | |
| 0.184 | 0.022 | 0.184 | Nav1.1 sodium channel blocker | 0.167 0.027 DBMET01809 0.174 0.025 DBMET01810 0.088 0.084 DBMET01811 | ||
| 0.174 | 0.013 | 0.174 | 5 Hydroxytryptamine uptake inhibitor | 0.086 0.032 DBMET01809 0.09 0.03 DBMET01810 0.163 0.014 DBMET01811 | ||
| 0.201 | 0.042 | 0.201 | Acetylcholine M1 receptor antagonist | 0.186 0.049 DBMET01809 0.198 0.043 DBMET01810 0.165 0.062 DBMET01811 | ||
| 0.18 | 0.025 | 0.18 | Butyrylcholinesterase inhibitor | 0.154 0.033 DBMET01809 0.145 0.036 DBMET01810 0.107 0.056 DBMET01811 | ||
| 0.163 | 0.01 | 0.2 | Acetylcholine M3 receptor antagonist | 0.178 0.008 DBMET01809 0.2 0.007 DBMET01810 0.165 0.01 DBMET01811 | DBMET01810 | |
| 0.181 | 0.028 | 0.181 | Nav1.6 sodium channel blocker | 0.148 0.057 DBMET01809 0.153 0.051 DBMET01810 0.128 0.084 DBMET01811 | ||
| 0.265 | 0.117 | 0.269 | Vasodilator, peripheral | 0.266 0.116 DBMET01809 0.269 0.114 DBMET01810 0.2 0.176 DBMET01811 | DBMET01810 | |
| 0.152 | 0.004 | 0.175 | CC chemokine 5 receptor agonist | 0.175 0.003 DBMET01809 0.168 0.003 DBMET01810 0.12 0.008 DBMET01811 | DBMET01809 | |
| 0.293 | 0.147 | 0.293 | Analgesic | 0.255 0.179 DBMET01809 0.268 0.167 DBMET01810 0.261 0.173 DBMET01811 | ||
| 0.188 | 0.045 | 0.194 | Death-associated protein kinase 2 inhibitor | 0.193 0.04 DBMET01809 0.194 0.04 DBMET01810 0.146 0.117 DBMET01811 | DBMET01810 | |
| 0.146 | 0.005 | 0.146 | Sigma 1 receptor antagonist | 0.072 0.008 DBMET01809 0.077 0.008 DBMET01810 0.041 0.012 DBMET01811 | ||
| 0.146 | 0.008 | 0.146 | 5 Hydroxytryptamine 5A antagonist | 0.112 0.013 DBMET01809 0.113 0.013 DBMET01810 0.084 0.021 DBMET01811 | ||
| 0.151 | 0.015 | 0.178 | Analgesic, opioid | 0.177 0.011 DBMET01809 0.178 0.011 DBMET01810 0.102 0.03 DBMET01811 | DBMET01810 | |
| 0.164 | 0.033 | 0.164 | Alpha 2b adrenoreceptor antagonist | 0.143 0.042 DBMET01809 0.138 0.045 DBMET01810 0.159 0.035 DBMET01811 | ||
| 0.151 | 0.022 | 0.191 | Nitric-oxide synthase inhibitor | 0.1 0.06 DBMET01809 0.106 0.051 DBMET01810 0.191 0.011 DBMET01811 | DBMET01811 | |
| 0.15 | 0.022 | 0.185 | 5 Hydroxytryptamine agonist | 0.185 0.016 DBMET01811 | DBMET01811 | |
| 0.158 | 0.03 | 0.158 | Antihistaminic | 0.124 0.041 DBMET01811 | ||
| 0.137 | 0.012 | 0.137 | Dopamine uptake inhibitor | 0.095 0.02 DBMET01809 0.1 0.018 DBMET01810 0.11 0.016 DBMET01811 | ||
| 0.26 | 0.136 | 0.26 | Calcium channel activator | 0.234 0.167 DBMET01809 0.245 0.153 DBMET01810 0.218 0.187 DBMET01811 | ||
| 0.133 | 0.009 | 0.133 | 5 Hydroxytryptamine 5 antagonist | 0.094 0.016 DBMET01809 0.096 0.016 DBMET01810 0.073 0.024 DBMET01811 | ||
| 0.137 | 0.014 | 0.137 | 5 Hydroxytryptamine 1D antagonist | 0.079 0.031 DBMET01809 0.074 0.035 DBMET01810 0.094 0.025 DBMET01811 | ||
| 0.25 | 0.126 | 0.267 | Antithrombotic | 0.266 0.114 DBMET01809 0.267 0.113 DBMET01810 0.206 0.17 DBMET01811 | DBMET01810 | |
| 0.195 | 0.072 | 0.237 | 5 Hydroxytryptamine 3E antagonist | 0.237 0.023 DBMET01811 | DBMET01811 | |
| 0.15 | 0.029 | 0.15 | Histamine antagonist | 0.117 0.04 DBMET01811 | ||
| 0.132 | 0.012 | 0.195 | 5 Hydroxytryptamine 1A agonist | 0.057 0.026 DBMET01809 0.059 0.025 DBMET01810 0.195 0.009 DBMET01811 | DBMET01811 | |
| 0.263 | 0.143 | 0.299 | GABA C receptor rho-3 antagonist | 0.263 0.143 DBMET01809 0.299 0.117 DBMET01810 0.273 0.135 DBMET01811 | DBMET01810 | |
| 0.15 | 0.032 | 0.15 | Chemokine receptor antagonist | 0.084 0.082 DBMET01809 0.095 0.068 DBMET01810 0.144 0.035 DBMET01811 | ||
| 0.132 | 0.014 | 0.132 | Acetylcholine M4 receptor antagonist | 0.081 0.045 DBMET01809 0.084 0.042 DBMET01810 0.093 0.034 DBMET01811 | ||
| 0.129 | 0.012 | 0.129 | Viral attachment inhibitor | 0.093 0.029 DBMET01809 0.096 0.027 DBMET01810 0.105 0.02 DBMET01811 | ||
| 0.122 | 0.005 | 0.129 | Dopamine D3 agonist | 0.101 0.007 DBMET01809 0.102 0.006 DBMET01810 0.129 0.005 DBMET01811 | DBMET01811 | |
| 0.13 | 0.018 | 0.13 | Dopamine D3 antagonist | 0.106 0.023 DBMET01809 0.103 0.024 DBMET01810 0.109 0.023 DBMET01811 | ||
| 0.224 | 0.114 | 0.23 | Gastrin inhibitor | 0.23 0.105 DBMET01811 | DBMET01811 | |
| 0.13 | 0.022 | 0.199 | Glutamate (mGluR7) agonist | 0.095 0.07 DBMET01810 0.199 0.004 DBMET01811 | DBMET01811 | |
| 0.138 | 0.03 | 0.138 | Sphingomyelinase inhibitor | 0.108 0.051 DBMET01809 0.119 0.042 DBMET01810 0.099 0.06 DBMET01811 | ||
| 0.137 | 0.03 | 0.177 | Opioid antagonist | 0.177 0.019 DBMET01809 0.177 0.019 DBMET01810 0.13 0.032 DBMET01811 | DBMET01810 | |
| 0.142 | 0.036 | 0.142 | Alpha 2c adrenoreceptor antagonist | 0.131 0.042 DBMET01809 0.124 0.046 DBMET01810 0.137 0.039 DBMET01811 | ||
| 0.128 | 0.025 | 0.128 | Histamine N-methyltransferase inhibitor | 0.119 0.03 DBMET01809 0.121 0.029 DBMET01810 | ||
| 0.131 | 0.029 | 0.131 | Histamine H1 receptor antagonist | 0.072 0.066 DBMET01809 0.078 0.059 DBMET01810 0.11 0.036 DBMET01811 | ||
| 0.122 | 0.019 | 0.239 | Dopamine D1 antagonist | 0.239 0.008 DBMET01809 0.205 0.01 DBMET01810 0.076 0.035 DBMET01811 | DBMET01809 | |
| 0.117 | 0.015 | 0.117 | Adrenaline uptake inhibitor | 0.077 0.029 DBMET01809 0.079 0.028 DBMET01810 0.111 0.016 DBMET01811 | ||
| 0.139 | 0.037 | 0.158 | GABA C receptor antagonist | 0.123 0.049 DBMET01809 0.132 0.042 DBMET01810 0.158 0.026 DBMET01811 | DBMET01811 | |
| 0.124 | 0.022 | 0.124 | 5 Hydroxytryptamine 1F antagonist | 0.067 0.052 DBMET01809 0.073 0.048 DBMET01810 0.067 0.052 DBMET01811 | ||
| 0.125 | 0.025 | 0.17 | Opioid delta receptor antagonist | 0.168 0.016 DBMET01809 0.17 0.016 DBMET01810 0.101 0.03 DBMET01811 | DBMET01810 | |
| 0.189 | 0.091 | 0.189 | Anticonvulsant | 0.147 0.133 DBMET01811 | ||
| 0.184 | 0.087 | 0.328 | Amyloid beta aggregation inhibitor | 0.328 0.039 DBMET01809 0.308 0.044 DBMET01810 | DBMET01809 | |
| 0.124 | 0.029 | 0.131 | 5 Hydroxytryptamine 1 antagonist | 0.081 0.046 DBMET01809 0.079 0.047 DBMET01810 0.131 0.027 DBMET01811 | DBMET01811 | |
| 0.168 | 0.073 | 0.174 | ATPase inhibitor | 0.168 0.074 DBMET01809 0.174 0.066 DBMET01810 | DBMET01810 | |
| 0.101 | 0.008 | 0.101 | CC chemokine 5 receptor antagonist | 0.064 0.022 DBMET01809 0.069 0.019 DBMET01810 0.092 0.01 DBMET01811 | ||
| 0.099 | 0.007 | 0.099 | Growth hormone secretagogue receptor antagonist | 0.035 0.025 DBMET01809 0.039 0.023 DBMET01810 | ||
| 0.12 | 0.028 | 0.154 | Porphobilinogen synthase inhibitor | 0.127 0.026 DBMET01809 0.154 0.02 DBMET01810 | DBMET01810 | |
| 0.117 | 0.026 | 0.157 | Opioid mu receptor antagonist | 0.157 0.016 DBMET01809 0.157 0.016 DBMET01810 0.115 0.026 DBMET01811 | DBMET01810 | |
| 0.096 | 0.005 | 0.096 | Sigma 2 receptor antagonist | 0.093 0.005 DBMET01809 0.087 0.005 DBMET01810 0.039 0.013 DBMET01811 | ||
| 0.111 | 0.024 | 0.111 | Glycine receptor antagonist | 0.089 0.044 DBMET01809 0.09 0.043 DBMET01810 | ||
| 0.113 | 0.026 | 0.165 | Opioid kappa receptor antagonist | 0.165 0.014 DBMET01809 0.162 0.015 DBMET01810 0.095 0.04 DBMET01811 | DBMET01809 | |
| 0.107 | 0.022 | 0.122 | Leukotriene synthesis inhibitor | 0.122 0.016 DBMET01809 0.117 0.018 DBMET01810 0.097 0.028 DBMET01811 | DBMET01809 | |
| 0.116 | 0.033 | 0.116 | Dopamine antagonist | 0.116 0.033 DBMET01809 0.108 0.035 DBMET01810 0.095 0.04 DBMET01811 | ||
| 0.114 | 0.035 | 0.114 | ABCA1 expression enhancer | 0.114 0.035 DBMET01809 0.113 0.036 DBMET01810 0.083 0.08 DBMET01811 | ||
| 0.176 | 0.099 | 0.226 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.226 0.054 DBMET01809 0.224 0.055 DBMET01810 | DBMET01809 | |
| 0.142 | 0.066 | 0.142 | Ca2+-transporting ATPase inhibitor | 0.135 0.093 DBMET01809 0.139 0.075 DBMET01810 0.132 0.111 DBMET01811 | ||
| 0.121 | 0.046 | 0.121 | Acetylcholine release stimulant | |||
| 0.109 | 0.036 | 0.109 | NADH dehydrogenase inhibitor | 0.106 0.038 DBMET01809 0.108 0.037 DBMET01810 | ||
| 0.13 | 0.059 | 0.135 | 5 Hydroxytryptamine antagonist | 0.135 0.056 DBMET01811 | DBMET01811 | |
| 0.187 | 0.116 | 0.218 | Vasodilator | 0.218 0.091 DBMET01809 0.217 0.091 DBMET01810 | DBMET01809 | |
| 0.134 | 0.063 | 0.16 | Cyclooxygenase 3 inhibitor | 0.16 0.04 DBMET01809 0.154 0.045 DBMET01810 | DBMET01809 | |
| 0.071 | 0.002 | 0.071 | Histone-lysine N-methyltransferase EZH2 inhibitor | 0.056 0.002 DBMET01809 0.058 0.002 DBMET01810 0.068 0.002 DBMET01811 | ||
| 0.125 | 0.056 | 0.125 | 5 Hydroxytryptamine 2B antagonist | 0.094 0.091 DBMET01809 0.095 0.09 DBMET01810 0.102 0.081 DBMET01811 | ||
| 0.079 | 0.011 | 0.079 | Prolactin release inhibitor | 0.077 0.014 DBMET01809 0.077 0.013 DBMET01810 0.072 0.019 DBMET01811 | ||
| 0.113 | 0.046 | 0.164 | GABA C receptor rho-1 antagonist | 0.098 0.065 DBMET01809 0.102 0.06 DBMET01810 0.164 0.016 DBMET01811 | DBMET01811 | |
| 0.1 | 0.033 | 0.1 | Telomerase inhibitor | 0.083 0.043 DBMET01809 0.083 0.043 DBMET01810 | ||
| 0.081 | 0.017 | 0.084 | Dopamine transporter inhibitor | 0.052 0.031 DBMET01809 0.055 0.028 DBMET01810 0.084 0.016 DBMET01811 | DBMET01811 | |
| 0.119 | 0.055 | 0.198 | Chelator | 0.186 0.027 DBMET01809 0.198 0.025 DBMET01810 0.096 0.083 DBMET01811 | DBMET01810 | |
| 0.172 | 0.108 | 0.172 | HERG channel blocker | |||
| 0.106 | 0.044 | 0.106 | Calcium antagonist | 0.097 0.05 DBMET01811 | ||
| 0.075 | 0.013 | 0.087 | Potassium channel Kv1.3 blocker | 0.069 0.016 DBMET01809 0.077 0.013 DBMET01810 0.087 0.01 DBMET01811 | DBMET01811 | |
| 0.095 | 0.034 | 0.102 | 5 Hydroxytryptamine 1A antagonist | 0.067 0.048 DBMET01809 0.065 0.049 DBMET01810 0.102 0.031 DBMET01811 | DBMET01811 | |
| 0.115 | 0.053 | 0.115 | GABA C receptor agonist | 0.096 0.071 DBMET01810 0.108 0.059 DBMET01811 | ||
| 0.089 | 0.029 | 0.089 | 5 Hydroxytryptamine 1B antagonist | 0.06 0.051 DBMET01811 | ||
| 0.133 | 0.074 | 0.133 | Toll-Like receptor 9 antagonist | 0.108 0.1 DBMET01809 | ||
| 0.141 | 0.083 | 0.351 | Peroxidase inhibitor | 0.351 0.028 DBMET01809 0.343 0.029 DBMET01810 | DBMET01809 | |
| 0.099 | 0.044 | 0.11 | Glutamate release inhibitor | 0.088 0.068 DBMET01809 0.091 0.059 DBMET01810 0.11 0.03 DBMET01811 | DBMET01811 | |
| 0.127 | 0.072 | 0.135 | Alpha-N-acetylglucosaminidase inhibitor | 0.135 0.065 DBMET01811 | DBMET01811 | |
| 0.139 | 0.084 | 0.158 | Adenylate cyclase stimulant | 0.158 0.051 DBMET01809 0.156 0.053 DBMET01810 0.156 0.053 DBMET01811 | DBMET01809 | |
| 0.097 | 0.042 | 0.132 | Neuropeptide Y antagonist | 0.075 0.068 DBMET01810 0.132 0.026 DBMET01811 | DBMET01811 | |
| 0.115 | 0.061 | 0.124 | DNA intercalator | 0.124 0.055 DBMET01809 0.116 0.06 DBMET01810 | DBMET01809 | |
| 0.153 | 0.1 | 0.181 | Phospholipase C inhibitor | 0.176 0.065 DBMET01809 0.181 0.06 DBMET01810 0.15 0.106 DBMET01811 | DBMET01810 | |
| 0.093 | 0.04 | 0.093 | Alpha 2a adrenoreceptor antagonist | 0.092 0.04 DBMET01809 0.084 0.045 DBMET01810 0.087 0.043 DBMET01811 | ||
| 0.095 | 0.043 | 0.095 | Acetylcholine nicotinic antagonist | 0.072 0.065 DBMET01809 0.072 0.066 DBMET01810 0.073 0.064 DBMET01811 | ||
| 0.057 | 0.005 | 0.057 | GHS receptor antagonist | 0.036 0.016 DBMET01809 0.036 0.016 DBMET01810 | ||
| 0.074 | 0.023 | 0.074 | Potassium channel (Ca-activated) blocker | |||
| 0.074 | 0.023 | 0.074 | Corticotropin releasing factor 2 receptor antagonist | 0.069 0.029 DBMET01811 | ||
| 0.089 | 0.039 | 0.089 | Interferon agonist | 0.074 0.062 DBMET01809 0.078 0.056 DBMET01810 | ||
| 0.08 | 0.031 | 0.095 | CXC chemokine 4 receptor antagonist | 0.058 0.044 DBMET01809 0.064 0.039 DBMET01810 0.095 0.026 DBMET01811 | DBMET01811 | |
| 0.069 | 0.023 | 0.074 | Glucosylceramidase inhibitor | 0.056 0.037 DBMET01809 0.064 0.026 DBMET01810 0.074 0.019 DBMET01811 | DBMET01811 | |
| 0.096 | 0.051 | 0.096 | Alpha 2 adrenoreceptor antagonist | 0.086 0.059 DBMET01809 0.081 0.065 DBMET01810 0.089 0.056 DBMET01811 | ||
| 0.063 | 0.018 | 0.068 | Squalene epoxidase inhibitor | 0.068 0.015 DBMET01809 0.065 0.016 DBMET01810 | DBMET01809 | |
| 0.058 | 0.015 | 0.058 | Geranyltranstransferase inhibitor | 0.045 0.029 DBMET01809 0.051 0.022 DBMET01810 0.052 0.021 DBMET01811 | ||
| 0.115 | 0.072 | 0.115 | Vascular endothelial growth factor antagonist | |||
| 0.087 | 0.045 | 0.087 | CC chemokine receptor antagonist | 0.084 0.047 DBMET01811 | ||
| 0.077 | 0.036 | 0.077 | Fibroblast growth factor 2 antagonist | 0.061 0.05 DBMET01809 0.077 0.035 DBMET01811 | ||
| 0.055 | 0.014 | 0.105 | Dopamine D5 agonist | 0.105 0.004 DBMET01809 0.095 0.004 DBMET01810 0.052 0.016 DBMET01811 | DBMET01809 | |
| 0.065 | 0.026 | 0.087 | Opioid agonist | 0.085 0.017 DBMET01809 0.087 0.017 DBMET01810 0.048 0.043 DBMET01811 | DBMET01810 | |
| 0.107 | 0.067 | 0.107 | Vascular endothelial growth factor 2 antagonist | |||
| 0.112 | 0.074 | 0.137 | Adenylate cyclase inhibitor | 0.137 0.054 DBMET01809 0.135 0.055 DBMET01810 0.126 0.063 DBMET01811 | DBMET01809 | |
| 0.088 | 0.05 | 0.102 | Histamine H2 receptor antagonist | 0.102 0.033 DBMET01811 | DBMET01811 | |
| 0.052 | 0.015 | 0.075 | Histamine H1 receptor agonist | 0.075 0.004 DBMET01811 | DBMET01811 | |
| 0.064 | 0.027 | 0.064 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.049 | 0.013 | 0.063 | Opioid delta receptor agonist | 0.061 0.009 DBMET01809 0.063 0.009 DBMET01810 0.034 0.026 DBMET01811 | DBMET01810 | |
| 0.071 | 0.036 | 0.073 | Dopamine D4 antagonist | 0.054 0.046 DBMET01809 0.053 0.047 DBMET01810 0.073 0.035 DBMET01811 | DBMET01811 | |
| 0.176 | 0.143 | 0.193 | Interleukin agonist | 0.162 0.156 DBMET01810 0.193 0.127 DBMET01811 | DBMET01811 | |
| 0.077 | 0.043 | 0.077 | Calcium channel L-type blocker | |||
| 0.056 | 0.023 | 0.056 | Histamine H3 receptor antagonist | 0.046 0.029 DBMET01811 | ||
| 0.049 | 0.017 | 0.052 | Kinesin-like protein 1 inhibitor | 0.052 0.016 DBMET01809 0.05 0.016 DBMET01810 | DBMET01809 | |
| 0.049 | 0.017 | 0.052 | Kinesin antagonist | 0.052 0.016 DBMET01809 0.05 0.016 DBMET01810 | DBMET01809 | |
| 0.102 | 0.07 | 0.102 | 5 Hydroxytryptamine 2 antagonist | 0.094 0.076 DBMET01811 | ||
| 0.057 | 0.027 | 0.057 | Potassium channel (Inward rectifier) blocker | |||
| 0.063 | 0.033 | 0.063 | Bcl-xL inhibitor | 0.061 0.036 DBMET01809 0.06 0.04 DBMET01810 | ||
| 0.097 | 0.067 | 0.097 | Aminopeptidase B inhibitor | 0.095 0.069 DBMET01810 0.096 0.068 DBMET01811 | ||
| 0.055 | 0.026 | 0.08 | Topoisomerase II beta inhibitor | 0.08 0.013 DBMET01809 0.073 0.015 DBMET01810 | DBMET01809 | |
| 0.069 | 0.042 | 0.069 | Potassium channel (ATP-sensitive) blocker | 0.063 0.054 DBMET01809 0.067 0.047 DBMET01810 | ||
| 0.036 | 0.011 | 0.047 | Dopamine autoreceptor agonist | 0.047 0.008 DBMET01809 0.047 0.008 DBMET01810 0.025 0.016 DBMET01811 | DBMET01810 | |
| 0.065 | 0.042 | 0.09 | Beta 3 adrenoreceptor antagonist | 0.088 0.019 DBMET01809 0.09 0.018 DBMET01810 0.07 0.033 DBMET01811 | DBMET01810 | |
| 0.042 | 0.019 | 0.042 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.101 | 0.079 | 0.101 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.049 | 0.026 | 0.061 | Dopamine D5 antagonist | 0.061 0.019 DBMET01809 0.058 0.02 DBMET01810 | DBMET01809 | |
| 0.032 | 0.01 | 0.032 | Corticotropin releasing factor 1 receptor antagonist | 0.022 0.017 DBMET01811 | ||
| 0.027 | 0.005 | 0.027 | CXC chemokine 5 receptor antagonist | 0.017 0.014 DBMET01810 0.021 0.008 DBMET01811 | ||
| 0.048 | 0.027 | 0.048 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.057 | 0.035 | 0.057 | Acyl-CoA dehydrogenase inhibitor | 0.054 0.038 DBMET01811 | ||
| 0.075 | 0.054 | 0.093 | GABA aminotransferase inhibitor | 0.082 0.044 DBMET01809 0.093 0.033 DBMET01810 0.084 0.042 DBMET01811 | DBMET01810 | |
| 0.033 | 0.012 | 0.033 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.056 | 0.036 | 0.059 | Epithelial sodium channel blocker | 0.051 0.048 DBMET01810 0.059 0.03 DBMET01811 | DBMET01811 | |
| 0.057 | 0.039 | 0.057 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.064 | 0.047 | 0.064 | Dopamine D2 antagonist | 0.063 0.047 DBMET01809 0.059 0.05 DBMET01810 | ||
| 0.042 | 0.026 | 0.042 | Plasmepsin II inhibitor | 0.038 0.036 DBMET01809 | ||
| 0.053 | 0.037 | 0.053 | 5 Hydroxytryptamine 1B agonist | 0.053 0.036 DBMET01811 | ||
| 0.059 | 0.043 | 0.059 | Alpha 2 adrenoreceptor agonist | |||
| 0.071 | 0.056 | 0.093 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.093 0.019 DBMET01811 | DBMET01811 | |
| 0.03 | 0.016 | 0.041 | Estrogen-related receptor gamma antagonist | 0.038 0.006 DBMET01809 0.041 0.005 DBMET01810 | DBMET01810 | |
| 0.08 | 0.067 | 0.104 | Estrogen-related receptor beta agonist | 0.104 0.021 DBMET01809 0.104 0.02 DBMET01810 0.08 0.068 DBMET01811 | DBMET01810 | |
| 0.11 | 0.097 | 0.121 | Sodium channel blocker | 0.121 0.083 DBMET01811 | DBMET01811 | |
| 0.088 | 0.077 | 0.088 | Electrolyte absorption antagonist | |||
| 0.034 | 0.024 | 0.034 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.049 | 0.039 | 0.084 | NMDA 2A receptor antagonist | 0.076 0.022 DBMET01809 0.077 0.021 DBMET01810 0.084 0.018 DBMET01811 | DBMET01811 | |
| 0.045 | 0.036 | 0.045 | CC chemokine 4 receptor antagonist | |||
| 0.057 | 0.048 | 0.057 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.036 | 0.028 | 0.036 | Delayed rectifier potassium channel blocker | |||
| 0.056 | 0.048 | 0.056 | Acetylcholine M5 receptor antagonist | 0.056 0.048 DBMET01811 | ||
| 0.043 | 0.036 | 0.068 | Opioid mu receptor agonist | 0.068 0.021 DBMET01809 0.068 0.02 DBMET01810 0.043 0.036 DBMET01811 | DBMET01810 | |
| 0.105 | 0.098 | 0.114 | Cathepsin H inhibitor | 0.114 0.083 DBMET01811 | DBMET01811 | |
| 0.038 | 0.032 | 0.065 | Glutamate (mGluR1a) antagonist | 0.065 0.013 DBMET01811 | DBMET01811 | |
| 0.113 | 0.107 | 0.114 | Neurotrophic factor | 0.113 0.107 DBMET01809 0.114 0.105 DBMET01810 | DBMET01810 | |
| 0.066 | 0.059 | 0.067 | Aminopeptidase I inhibitor | 0.067 0.058 DBMET01811 | DBMET01811 | |
| 0.124 | 0.118 | 0.16 | GABA C receptor rho-2 antagonist | 0.16 0.062 DBMET01811 | DBMET01811 | |
| 0.12 | 0.115 | 0.181 | NOS3 expression enhancer | 0.181 0.049 DBMET01809 0.176 0.052 DBMET01810 | DBMET01809 | |
| 0.122 | 0.117 | 0.17 | Neuropeptide Y1 antagonist | 0.127 0.106 DBMET01809 0.127 0.107 DBMET01810 0.17 0.039 DBMET01811 | DBMET01811 | |
| 0.038 | 0.034 | 0.038 | Phenylethanolamine N methyltransferase inhibitor | 0.037 0.035 DBMET01811 | ||
| 0.052 | 0.048 | 0.052 | 5 Hydroxytryptamine 7 agonist | |||
| 0.084 | 0.081 | 0.156 | Creatine kinase inhibitor | 0.156 0.021 DBMET01809 0.148 0.025 DBMET01810 | DBMET01809 | |
| 0.014 | 0.011 | 0.016 | Microsomal triglyceride transfer protein inhibitor | 0.016 0.009 DBMET01811 | DBMET01811 | |
| 0.036 | 0.034 | 0.039 | AMPA 4 receptor antagonist | 0.039 0.029 DBMET01811 | DBMET01811 | |
| 0.018 | 0.016 | 0.026 | Apolipoprotein B inhibitor | 0.026 0.009 DBMET01811 | DBMET01811 | |
| 0.027 | 0.025 | 0.027 | 5 Hydroxytryptamine 6 agonist | |||
| 0.114 | 0.113 | 0.161 | Sphingosine 1-phosphate receptor 2 antagonist | 0.161 0.029 DBMET01811 | DBMET01811 | |
| 0.032 | 0.032 | 0.069 | NMDA receptor subunit 3A antagonist | 0.067 0.015 DBMET01809 0.069 0.014 DBMET01810 | DBMET01810 | |
| 0.149 | 0.149 | 0.222 | Antiamyloidogenic | 0.222 0.085 DBMET01809 0.21 0.093 DBMET01810 | DBMET01809 | |
| 0.013 | 0.014 | 0.017 | NMDA receptor phencyclidine site antagonist | 0.017 0.009 DBMET01809 0.015 0.011 DBMET01810 | DBMET01809 | |
| 0.058 | 0.06 | 0.069 | Beta 2 adrenoreceptor agonist | 0.068 0.023 DBMET01809 0.069 0.021 DBMET01810 0.064 0.033 DBMET01811 | DBMET01810 | |
| 0.058 | 0.061 | 0.096 | Phenylalanine 4-hydroxylase inhibitor | 0.082 0.036 DBMET01809 0.096 0.028 DBMET01810 | DBMET01810 | |
| 0.067 | 0.073 | 0.08 | Vanilloid 4 agonist | 0.08 0.041 DBMET01811 | DBMET01811 | |
| 0.072 | 0.078 | 0.117 | Inducible nitric-oxide synthase inhibitor | 0.117 0.026 DBMET01811 | DBMET01811 | |
| 0.195 | 0.202 | 0.23 | Immunosuppressant | 0.23 0.166 DBMET01809 0.229 0.167 DBMET01810 | DBMET01809 | |
| 0.181 | 0.188 | 0.199 | Insulysin inhibitor | 0.189 0.174 DBMET01809 0.199 0.158 DBMET01810 | DBMET01810 | |
| 0.039 | 0.046 | 0.056 | AMPA receptor antagonist | 0.056 0.027 DBMET01811 | DBMET01811 | |
| 0.038 | 0.047 | 0.042 | Neuraminidase (Influenza A) inhibitor | 0.042 0.039 DBMET01810 | DBMET01810 | |
| 0.011 | 0.02 | 0.015 | CXC chemokine 4 receptor agonist | 0.015 0.011 DBMET01811 | DBMET01811 | |
| 0.014 | 0.023 | 0.018 | Apolipoprotein B-100 inhibitor | 0.018 0.013 DBMET01811 | DBMET01811 | |
| 0.049 | 0.059 | 0.066 | Sphingosine 1-phosphate receptor 1 antagonist | 0.066 0.021 DBMET01811 | DBMET01811 | |
| 0.023 | 0.035 | 0.028 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.028 0.018 DBMET01811 | DBMET01811 | |
| 0.081 | 0.095 | 0.102 | Anabolic | 0.102 0.06 DBMET01809 0.096 0.068 DBMET01810 | DBMET01809 | |
| 0.127 | 0.141 | 0.177 | DNA methylase inhibitor | 0.177 0.095 DBMET01809 0.159 0.11 DBMET01810 | DBMET01809 | |
| 0.065 | 0.082 | 0.112 | Estrogen receptor alpha antagonist | 0.112 0.021 DBMET01809 0.103 0.025 DBMET01810 | DBMET01809 | |
| 0.052 | 0.07 | 0.069 | Histone deacetylase inhibitor | 0.069 0.041 DBMET01811 | DBMET01811 | |
| 0.014 | 0.032 | 0.021 | Estrogen-related receptor gamma agonist | 0.019 0.012 DBMET01809 0.021 0.009 DBMET01810 | DBMET01810 | |
| 0.069 | 0.088 | 0.091 | MAP kinase kinase 7 inhibitor | 0.091 0.024 DBMET01809 0.086 0.031 DBMET01810 0.074 0.066 DBMET01811 | DBMET01809 | |
| 0.009 | 0.03 | 0.018 | Melatonin receptor 1A antagonist | 0.018 0.006 DBMET01811 | DBMET01811 | |
| 0.031 | 0.053 | 0.053 | NMDA receptor subunit 3B antagonist | 0.053 0.023 DBMET01809 0.052 0.024 DBMET01810 | DBMET01809 | |
| 0.051 | 0.073 | 0.058 | Ryanodine receptor antagonist | 0.058 0.044 DBMET01809 | DBMET01809 | |
| 0.132 | 0.155 | 0.172 | Neurotensin receptor agonist | 0.157 0.086 DBMET01809 0.155 0.089 DBMET01810 0.172 0.059 DBMET01811 | DBMET01811 | |
| 0.08 | 0.105 | 0.11 | 5 Hydroxytryptamine 3A agonist | 0.11 0.065 DBMET01811 | DBMET01811 | |
| 0.049 | 0.076 | 0.077 | Alpha adrenoreceptor agonist | 0.077 0.04 DBMET01811 | DBMET01811 | |
| 0.018 | 0.047 | 0.038 | Endothelial nitric-oxide synthase inhibitor | 0.038 0.015 DBMET01811 | DBMET01811 | |
| 0.049 | 0.078 | 0.071 | Beta adrenoreceptor antagonist | 0.07 0.039 DBMET01809 0.071 0.036 DBMET01810 0.064 0.048 DBMET01811 | DBMET01810 | |
| 0.179 | 0.21 | 0.259 | Calpain 2 inhibitor | 0.259 0.143 DBMET01811 | DBMET01811 | |
| 0.128 | 0.159 | 0.138 | Succinate dehydrogenase inhibitor | 0.138 0.136 DBMET01809 | DBMET01809 | |
| 0.117 | 0.15 | 0.158 | DNA methyltransferase I inhibitor | 0.158 0.096 DBMET01809 0.143 0.111 DBMET01810 | DBMET01809 | |
| 0.082 | 0.115 | 0.105 | Cholesterol synthesis inhibitor | 0.105 0.081 DBMET01809 0.105 0.081 DBMET01810 | DBMET01810 | |
| 0.09 | 0.124 | 0.101 | Interleukin 8 antagonist | 0.101 0.094 DBMET01809 0.099 0.098 DBMET01810 | DBMET01809 | |
| 0.046 | 0.081 | 0.06 | NMDA receptor agonist | 0.06 0.047 DBMET01811 | DBMET01811 | |
| 0.139 | 0.174 | 0.152 | Cyclic AMP phosphodiesterase inhibitor | 0.152 0.149 DBMET01809 | DBMET01809 | |
| 0.059 | 0.095 | 0.101 | Adrenaline agonist | 0.098 0.038 DBMET01809 0.101 0.036 DBMET01810 0.101 0.036 DBMET01811 | DBMET01811 | |
| 0.019 | 0.057 | 0.029 | Purinergic P2Y15 antagonist | 0.029 0.02 DBMET01811 | DBMET01811 | |
| 0.032 | 0.073 | 0.052 | Beta 2 adrenoreceptor antagonist | 0.051 0.035 DBMET01809 0.052 0.033 DBMET01810 0.049 0.038 DBMET01811 | DBMET01810 | |
| 0.062 | 0.104 | 0.108 | MAO A inhibitor | 0.108 0.059 DBMET01809 0.096 0.067 DBMET01810 | DBMET01809 | |
| 0.04 | 0.082 | 0.075 | Sphingosine 1-phosphate receptor 3 antagonist | 0.075 0.021 DBMET01811 | DBMET01811 | |
| 0.037 | 0.08 | 0.046 | Beta adrenoreceptor agonist | 0.046 0.03 DBMET01809 0.046 0.028 DBMET01810 0.044 0.037 DBMET01811 | DBMET01810 | |
| 0.013 | 0.056 | 0.035 | Melatonin antagonist | 0.035 0.013 DBMET01811 | DBMET01811 | |
| 0.013 | 0.058 | 0.021 | Dopamine D1 agonist | 0.021 0.02 DBMET01809 | DBMET01809 | |
| 0.036 | 0.082 | 0.053 | Alpha 1 adrenoreceptor agonist | 0.053 0.046 DBMET01811 | DBMET01811 | |
| 0.009 | 0.057 | 0.02 | Melatonin 1 antagonist | 0.02 0.012 DBMET01811 | DBMET01811 | |
| 0.033 | 0.083 | 0.051 | Beta 1 adrenoreceptor antagonist | 0.051 0.045 DBMET01810 0.049 0.047 DBMET01811 | DBMET01810 | |
| 0.072 | 0.122 | 0.147 | Topoisomerase II inhibitor | 0.147 0.051 DBMET01809 0.134 0.058 DBMET01810 | DBMET01809 | |
| 0.081 | 0.133 | 0.097 | TRPA1 agonist | 0.097 0.094 DBMET01809 | DBMET01809 | |
| 0.025 | 0.077 | 0.053 | Antimetabolite | 0.053 0.03 DBMET01811 | DBMET01811 | |
| 0.072 | 0.126 | 0.115 | MAO inhibitor | 0.115 0.077 DBMET01809 0.106 0.085 DBMET01810 | DBMET01809 | |
| 0.06 | 0.115 | 0.082 | Sphingosine 1-phosphate receptor antagonist | 0.082 0.041 DBMET01811 | DBMET01811 | |
| 0.051 | 0.109 | 0.086 | Ornithine decarboxylase inhibitor | 0.086 0.06 DBMET01811 | DBMET01811 | |
| 0.031 | 0.092 | 0.063 | Histamine agonist | 0.063 0.025 DBMET01811 | DBMET01811 | |
| 0.058 | 0.131 | 0.087 | Alcohol dehydrogenase inhibitor | 0.087 0.068 DBMET01809 0.084 0.074 DBMET01810 | DBMET01809 | |
| 0.143 | 0.218 | 0.211 | DNA synthesis inhibitor | 0.211 0.106 DBMET01811 | DBMET01811 | |
| 0.131 | 0.207 | 0.2 | Calpain inhibitor | 0.2 0.114 DBMET01811 | DBMET01811 | |
| 0.076 | 0.156 | 0.106 | Aldehyde dehydrogenase inhibitor | 0.104 0.092 DBMET01809 0.106 0.089 DBMET01810 | DBMET01810 | |
| 0.02 | 0.1 | 0.031 | Melatonin receptor 1A agonist | 0.031 0.028 DBMET01811 | DBMET01811 | |
| 0.024 | 0.106 | 0.062 | Glutamate (mGluR1) antagonist | 0.062 0.037 DBMET01811 | DBMET01811 | |
| 0.048 | 0.132 | 0.077 | NMDA receptor antagonist | 0.076 0.071 DBMET01809 0.077 0.069 DBMET01810 | DBMET01810 | |
| 0.029 | 0.116 | 0.054 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.054 0.036 DBMET01809 0.05 0.043 DBMET01810 | DBMET01809 | |
| 0.16 | 0.264 | 0.22 | Histamine release inhibitor | 0.22 0.18 DBMET01809 0.208 0.193 DBMET01810 | DBMET01809 | |
| 0.072 | 0.177 | 0.157 | Estrogen antagonist | 0.157 0.021 DBMET01809 0.148 0.024 DBMET01810 | DBMET01809 | |
| 0.066 | 0.186 | 0.1 | DOPA decarboxylase inhibitor | 0.1 0.075 DBMET01809 0.095 0.087 DBMET01810 | DBMET01809 | |
| 0.049 | 0.172 | 0.083 | Aminoacyl-tRNA synthetase inhibitor | 0.083 0.071 DBMET01811 | DBMET01811 | |
| 0.148 | 0.28 | 0.237 | Caspase 3 stimulant | 0.237 0.124 DBMET01809 0.218 0.145 DBMET01810 | DBMET01809 | |
| 0.066 | 0.2 | 0.104 | Toll-Like receptor 2 antagonist | 0.104 0.098 DBMET01809 | DBMET01809 | |
| 0.098 | 0.246 | 0.15 | Neurotrophic factor enhancer | 0.15 0.138 DBMET01809 | DBMET01809 | |
| 0.168 | 0.325 | 0.299 | Apoptosis agonist | 0.299 0.173 DBMET01809 0.276 0.19 DBMET01810 | DBMET01809 | |
| 0.034 | 0.192 | 0.081 | Antiadrenergic | 0.081 0.07 DBMET01811 | DBMET01811 | |
| 0.031 | 0.205 | 0.078 | Adrenaline antagonist | 0.078 0.07 DBMET01811 | DBMET01811 | |
| 0.05 | 0.227 | 0.152 | Lipid peroxidase inhibitor | 0.152 0.067 DBMET01809 0.145 0.072 DBMET01810 | DBMET01809 | |
| 0.017 | 0.198 | 0.028 | DNA topoisomerase IV inhibitor | 0.028 0.026 DBMET01811 | DBMET01811 | |
| 0.037 | 0.243 | 0.107 | Bronchodilator | 0.107 0.056 DBMET01811 | DBMET01811 | |
| 0.007 | 0.226 | 0.053 | Estrogen agonist | 0.053 0.034 DBMET01809 0.044 0.04 DBMET01810 | DBMET01809 | |
| 0.011 | 0.335 | 0.033 | Estrogen-related receptor beta antagonist | 0.033 0.021 DBMET01809 0.03 0.029 DBMET01810 | DBMET01809 | |
| 0.031 | 0.355 | 0.122 | Estrogen receptor beta antagonist | 0.122 0.03 DBMET01809 0.118 0.034 DBMET01810 | DBMET01809 | |
| 0.048 | 0.385 | 0.205 | Free radical scavenger | 0.205 0.094 DBMET01809 0.193 0.104 DBMET01810 | DBMET01809 | |
| 0.054 | 0.402 | 0.201 | Antioxidant | 0.201 0.113 DBMET01809 0.189 0.123 DBMET01810 | DBMET01809 | |
| 0.127 | 0.476 | 0.279 | Calcium channel L-type activator | 0.253 0.202 DBMET01809 0.279 0.175 DBMET01810 | DBMET01810 | |
| 0.011 | 0.415 | 0.07 | DNA gyrase inhibitor | 0.07 0.036 DBMET01811 | DBMET01811 | |
| 0.074 | 0.49 | 0.228 | Sodium/bile acid cotransporter inhibitor | 0.228 0.153 DBMET01809 0.212 0.172 DBMET01810 | DBMET01809 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |